Financhill
Sell
36

ALTS Quote, Financials, Valuation and Earnings

Last price:
$2.20
Seasonality move :
22.4%
Day range:
$2.05 - $2.32
52-week range:
$1.08 - $10.95
Dividend yield:
0%
P/E ratio:
0.14x
P/S ratio:
4.80x
P/B ratio:
0.18x
Volume:
4.2M
Avg. volume:
5M
1-year change:
-53%
Market cap:
$276.4M
Revenue:
$12.5M
EPS (TTM):
-$1.05

Analysts' Opinion

  • Consensus Rating
    ALT5 Sigma Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $18.00, ALT5 Sigma Corp. has an estimated upside of 721.92% from its current price of $2.19.
  • Price Target Downside
    According to analysts, the lowest downside price target is $18.00 representing 100% downside risk from its current price of $2.19.

Fair Value

  • According to the consensus of 1 analyst, ALT5 Sigma Corp. has 721.92% upside to fair value with a price target of $18.00 per share.

ALTS vs. S&P 500

  • Over the past 5 trading days, ALT5 Sigma Corp. has underperformed the S&P 500 by -9.19% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • ALT5 Sigma Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • ALT5 Sigma Corp. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter ALT5 Sigma Corp. reported revenues of $6.4M.

Earnings Growth

  • ALT5 Sigma Corp. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter ALT5 Sigma Corp. reported earnings per share of -$0.49.
Enterprise value:
311.3M
EV / Invested capital:
--
Price / LTM sales:
4.80x
EV / EBIT:
--
EV / Revenue:
12.51x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-17.86x
Price / Operating cash flow:
117.03x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$5.4M
Return On Assets:
-16.1%
Net Income Margin (TTM):
-58.65%
Return On Equity:
-46.02%
Return On Invested Capital:
-30.54%
Operating Margin:
-32.85%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue -- $7.1M $24.9M $4.9M $7.6M
Gross Profit -$1.1M $2.7M $6.8M $2.2M $1.7M
Operating Income -$4.1M -$6.1M -$22.4M -$732K -$16.5M
EBITDA -$3M -$5.3M -$18.4M -$518K -$15.6M
Diluted EPS -$0.49 -$3.12 -$0.64 -$0.06 $0.29
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $10.7M $9.4M $517K $31.9M $44.8M
Total Assets $27.6M $29.6M $34.5M $74.9M $1.6B
Current Liabilities $20.6M $23.8M $2.5M $42.3M $56.4M
Total Liabilities $24.9M $30.2M $5.5M $50.8M $80.1M
Total Equity $2.7M -$575K $29M $24.1M $1.6B
Total Debt $3.9M $6.7M -- $10.7M $17.2M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $1.2M $3.3M -$17.4M $4.2M -$8.7M
Cash From Investing -$715K $5.9M -$711.3M -- -$711.4M
Cash From Financing -$960K $2.1M $723.4M $900K $715.7M
Free Cash Flow $647K $3.3M -$17.4M $4.2M -$8.8M
ALTS
Sector
Market Cap
$276.4M
$537.1M
Price % of 52-Week High
20%
91.44%
Dividend Yield
0%
1.51%
Shareholder Yield
-3.06%
3.06%
1-Year Price Total Return
-53%
7.41%
Beta (5-Year)
1.658
0.451
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $2.33
200-day SMA
Sell
Level $4.74
Bollinger Bands (100)
Sell
Level 1.4 - 3.26
Chaikin Money Flow
Sell
Level -281.6M
20-day SMA
Buy
Level $1.75
Relative Strength Index (RSI14)
Buy
Level 60.64
ADX Line
Buy
Level 36.28
Williams %R
Neutral
Level -37.931
50-day SMA
Buy
Level $1.67
MACD (12, 26)
Buy
Level 0.24
25-day Aroon Oscillator
Buy
Level 48
On Balance Volume
Neutral
Level 207.6M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-0.1607)
Sell
CA Score (Annual)
Level (-1.7042)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (4.1856)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (2)

Revenue Forecast

Earnings per Share Forecast

Company Profile

ALT5 Sigma Corp. is a multidisciplinary organization with a focus on healthcare and fintech. The firm provides blockchain-powered technologies to enable a migration to a new global financial paradigm for the trading, clearing, settlement, payment, and custodianship of digital instruments. It operates through the following segments: Biotechnology and Corporate and Other. The Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Corporate and Other segment consists of certain corporate general and administrative costs. Its platforms: ALT5 Pay and ALT5 Prime. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.

Stock Forecast FAQ

In the current month, ALTS has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ALTS average analyst price target in the past 3 months is $18.00.

  • Where Will ALT5 Sigma Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that ALT5 Sigma Corp. share price will rise to $18.00 per share over the next 12 months.

  • What Do Analysts Say About ALT5 Sigma Corp.?

    Analysts are divided on their view about ALT5 Sigma Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ALT5 Sigma Corp. is a Sell and believe this share price will drop from its current level to $18.00.

  • What Is ALT5 Sigma Corp.'s Price Target?

    The price target for ALT5 Sigma Corp. over the next 1-year time period is forecast to be $18.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is ALTS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for ALT5 Sigma Corp. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.

  • How Can I Buy Shares Of ALTS?

    You can purchase shares of ALT5 Sigma Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ALT5 Sigma Corp. shares.

  • What Is The ALT5 Sigma Corp. Share Price Today?

    ALT5 Sigma Corp. was last trading at $2.20 per share. This represents the most recent stock quote for ALT5 Sigma Corp.. Yesterday, ALT5 Sigma Corp. closed at $2.19 per share.

  • How To Buy ALT5 Sigma Corp. Stock Online?

    In order to purchase ALT5 Sigma Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did AMD Stock Go Up?
Why Did AMD Stock Go Up?

Since January 9th, shares of chipmaker AMD (NASDAQ:AMD) have been…

Will Data Centers Be In Space?
Will Data Centers Be In Space?

With demand for data centers seemingly growing by the day,…

Why Did SoundHound AI Stock Go Up?
Why Did SoundHound AI Stock Go Up?

SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
47
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
56
INTC alert for Jan 24

Intel Corp. [INTC] is down 17.01% over the past day.

Buy
64
BNR alert for Jan 24

Burning Rock Biotech Ltd. [BNR] is down 12.81% over the past day.

Sell
19
APGE alert for Jan 24

Apogee Therapeutics, Inc. [APGE] is down 12.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock